Health Catalyst, Inc. (2YP.F)
| Previous Close | 10.20 |
| Open | 10.20 |
| Bid | 10.20 x N/A |
| Ask | 10.60 x N/A |
| Day's Range | 10.20 - 10.20 |
| 52 Week Range | 6.55 - 24.80 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 572.359M |
| Beta (5Y Monthly) | 1.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.41 |
| Earnings Date | May 08, 2023 - May 12, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 66.00 |
- Zacks
NextGen (NXGN) Riding on the Success of Cloud-Based Solution
NextGen's (NXGN) cloud-based healthcare technology solutions boost the company's prospect. Strong adoption of its services continues to boost revenues.
- GlobeNewswire
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, March 07, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the 44th Annual Raymond James Institutional Investors Conference, being held in Orlando, including a presentation on Wednesday, March 8, 2023 at 8:05a
- Motley Fool
Why Health Catalyst Stock Rallied Wednesday Morning
Shares of Health Catalyst (NASDAQ: HCAT) charged sharply higher Wednesday morning, surging as much as 13.7%. For its fourth quarter, Health Catalyst generated revenue of $69.2 million, up 7% year over year. Health Catalyst also announced that Matthew Kolb, executive vice president and chief operating officer of Carle Health, would be joining its board of directors effective July 1.
